Virax Biolabs Group annual total liabilities
2021
2022
2023
2024
2025
2026
Virax Biolabs Group Total Liabilities Growth & History (VRAX)
Virax Biolabs Group's total liabilities was $989,832 for fiscal 2026.
View full Virax Biolabs Group company overviewVirax Biolabs Group annual total liabilities history
| Fiscal year | Period ended | Total liabilities | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $989,832 | $25,082 | +2.60% |
| 2025 | 2025-03-31 | $964,750 | $619,556 | +179.48% |
| 2024 | 2024-03-31 | $345,194 | −$563,207 | −62.00% |
| 2023 | 2023-03-31 | $908,401 | −$337,013 | −27.06% |
| 2022 | 2022-03-31 | $1.2M | $373,979 | +42.92% |
| 2021 | 2021-03-31 | $871,435 | — | — |
Virax Biolabs Group quarterly total liabilities
Q4.21
Q4.22
Q4.23
Q4.24
Q4.25
Q2.26
Q4.26
| Fiscal quarter | Period ended | Total liabilities | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-03-31 | $989,832 | $25,082 | +2.60% |
| Q2 2026 | 2025-09-30 | $641,516 | — | — |
| Q4 2025 | 2025-03-31 | $964,750 | $619,556 | +179.48% |
| Q4 2024 | 2024-03-31 | $345,194 | −$563,207 | −62.00% |
| Q4 2023 | 2023-03-31 | $908,401 | −$337,013 | −27.06% |
| Q4 2022 | 2022-03-31 | $1.2M | $373,979 | +42.92% |
| Q4 2021 | 2021-03-31 | $871,435 | — | — |
Virax Biolabs Group total liabilities trends
Over the last five fiscal years, Virax Biolabs Group's total liabilities increased from $871,435 to $989,832, a change of $118,397. The latest reported quarter, Q4 2026, shows $989,832.
About the metric
What total liabilities mean
Total liabilities are all obligations reported on a company’s balance sheet, including debt, accounts payable, accrued expenses, deferred revenue, lease liabilities, and other current and long-term obligations.
Calculation and source
SEC-reported and calculated total liabilities
TickerStat uses total liabilities reported in company SEC filings when available. Otherwise, it calculates total liabilities as aligned total assets minus total equity for the same balance-sheet date. Total liabilities should not be confused with interest-bearing debt. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Virax Biolabs Group source filings ↗